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Abstract
Background: Alveolar echinococcosis (AE) is a lethal zoonosis caused by the fox-tapeworm Echinococcus multilocularis.
The disease is difficult to treat and an effective therapeutic drug is urgently needed. Reliable models are essential for
drug development. In this study, we developed both in vitro and in vivo models of larval E. multilocularis.
Results: The protoscoleces (PSC) of E. multilocularis from jirds were successfully cultured in a modified RPMI1640 based
medium containing 25 % (v/v) fetal bovine serum (FBS). After 100 days of culture, PSC developed to larval vesicles
(small unilocular cysts) and the fast growing vesicles produced PSC in brood capsules. In addition, mice were
intraperitoneally injected with 30 cultured small vesicles and 100 % of the mice had resulting metacestode masses.
Conclusions: Larval protoscoleces and vesicles of E. multilocularis grow healthily in vitro in the RPMI1640 based
medium containing 25 % FBS. Echinococcus multilocularis in vitro and in vivo models provide a valuable platform for
investigating the biology of the parasite and screening effective therapeutic drugs against AE.
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Background
Alveolar echinococcosis (AE) is one of the most lethal
helminthic infections in humans [1]. The disease is
caused by the fox-tapeworm Echinococcus multilocularis,
which occurs in most areas of the northern hemisphere
[2, 3]. Recent epidemiological studies showed that AE is
highly endemic in Central Asia, including western
China, Kazakhstan and Kyrgyzstan [4, 5]. AE is a chronic
parasitic disease and can remain asymptomatic in a pa-
tient for up to 15 years [6]. When an AE patient feels ill
and requests to see a doctor, it is normally at a late stage.
In this late stage, the parasite causes liver damage
through its production of an infiltrating structure con-
sisting of numerous small vesicles embedded in stroma
of connective tissue, which makes surgical resection
difficult and secondary re-infection often occurs [7].
Normally, surgical removal, if applicable, is the only
curative method for treating AE and patients have to
take albendazole (ABZ) and/or mebendazole (MBZ) after
surgical treatment for at least 2 years [8]. Inoperable AE
patients must undergo long term, often life-long, chemo-
therapy with ABZ and/or MBZ [9, 10]. Recent study has
shown that these drugs are not parasiticidal in vivo
against AE, and only inhibit E. multilocularis growth.
This is the reason that AE patients have to take the
drugs for a long time [11]. In addition, the occurrence of
side effects with these drugs has been often reported,
leading to discontinuation of treatment or to progressive
disease. An effective therapeutic drug for AE is urgently
needed.
Metacestodes of E. multilocularis are fluid-filled
grape-like vesicles. The asexually proliferating vesicles
cause the disease and the vesicles have been used for
drug screening [4, 12, 13]. A simple and stable method
for culturing the metacestodes of the parasite will be
beneficial not only for biological and physiological stud-
ies, but also for speeding up drug development against
AE. Several previous studies have achieved successful
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cultivation of E. multilocularis metacestodes in vitro.
The co-culture system contains host support or feeder
cells for the parasite to be maintained in medium for the
several months required to produce PSC. Without the
feeder cells, the metacestodes can be only maintained
for a few weeks [14–16].
In the present study, we cultured PSC of E. multilocu-
laris in a modified medium without host feeder cells. In
the culture system, PSC re-differentiate into vesicles
which can be maintained for more than 100 days and
the fast growing vesicles produced PSC in brood
capsules.
Methods
Animal infections and parasites
Mongolian jirds (Meriones unguiculatus) were used for
maintaining larval E. multilocularis in an animal house
at the Veterinary Research Institute, Xinjiang Academy
of Animal Science. Jirds were intraperitoneally (i.p.) in-
fected with PSC of E. multilocularis collected from Yili,
Xinjiang, China. Pathogen-free female BALB/c mice,
aged 6–8 weeks, were purchased from Beijing Vital River
Laboratory Animal Technology Company Limited, and
raised in the animal facility of the First Affiliated
Hospital of Xinjiang Medical University.
Collection of protoscoleces and in vitro cultivation
Mongolian jirds were infected with PSC of E. multilocu-
laris for 4–8 months, and those with a heavy infection
were sacrificed with CO2 anaesthesia. Metacestode
masses were collected from the peritoneal cavity of the
infected jirds under aseptic conditions and then washed
with sterile phosphate-buffered saline (PBS). After re-
moval of possible host tissues, the masses were minced
into small tissue pieces. The parasite tissues were then
passed through a sterilized sieve (100 mesh sieve) by
grounding with a glass pestle. The passed through para-
site tissues containing PSC were washed five times with
PBS containing 100 U/ml penicillin and 100 μg/ml
streptomycin (PBS-PS) by placing the tube on the bench
for 5 min to allow the PSC to sediment at room
temperature. The sedimented PSC were digested with
1 % (w/v) pepsin (Sigma-Aldrich, Louis, MO, USA) at
pH 2.0 (adjusted with 2 M HCl) in Hank's Buffer for
20 min at 37 °C. After the digestion procedure, the PSC
were washed five more times with PBS-PS to remove
debris by natural sedimentation for 5 min at room
temperature. The viability of PSC was determined by
staining with 0.1 % methylene blue, with dead PSC stain-
ing blue.
Only samples with ≥ 95 % viability were subsequently
cultured in RPMI 1640 medium (Gibco, Auckland, New
Zealand) containing 25 % (v/v) FBS (Gibco), 0.45 %
(w/v) yeast extract, 0.4 % (w/v) of glucose, 100 U/ml
penicillin and 100 μg/ml streptomycin in a culture
flask at 37 °C in the presence of 5 % CO2. The
medium was changed every 3 days. Each culture was
monitored weekly under an optical microscope to
check the growth status of the larval vesicles.
Animal infection
BALB/c mice were each i.p. transplanted with 30 small
(250–300 μm in diameter) cultured vesicles of E. multi-
locularis. After 6 months, parasitic masses were col-
lected from the mice and histopathological examination
was performed by hematoxylin and eosin staining.
Results and discussion
The genotype of the E. multilocularis Xinjiang Yili iso-
late used in this study was determined by sequencing
the mitochondrial cytochrome c oxidase subunit 1 (cox1)
gene. The sequence alignment showed 99.8 % identity to
the sequence (gi261399263) of an E. multilocularis iso-
late collected in Kazakhstan (data not shown). On the
first day of cultivation, we observed the culture con-
tained 60 % of invaginated and 40 % evaginated PSC.
The larval parasites had an even and smooth edge with
clearly distinct internal and external structures/organs
evident, including a rostellum, hooks, suckers and cal-
careous corpuscles (Fig. 1a). After 7 days of cultivation,
a majority (76 %) of the PSC were evaginated. The head
and neck region of the evaginated PSC were expanded
into a “swollen” shape (Fig. 1b). After 15 days, the PSC
were clearly differentiated into pre-microvesicles with
some internal and external structures evident. However,
the hooks and calcareous corpuscles had gradually
disappeared or had degenerated. Suckers were re-
positioned on the surface of the pre-microvesicles
(arrowed in Fig. 1c). After 60 days, most PSC were dead,
with only about 10 % of the PSC having developed into
microvesicles. At this time, a thin laminated layer was
observed in most vesicles under the microscope (Fig. 1d).
The vesicles could be seen by the naked eye at this stage.
As the dead PSC were normally sedimented, the micro-
vesicles were suspended by slightly shaking the culture
flask. Thus, the suspended microvesicles were easily sep-
arated from the dead PSC by simply transferring the sus-
pended vesicles into a fresh flask with a Pasteur pipette.
The culture system supported the healthy growth of the
vesicles for more than 100 days, when the small vesicles
grew to a mean diameter of 2.8 mm (Fig. 2a). Staining of
the sectioned vesicles with toluidine blue indicated the
small vesicles had a laminated layer; the germinal layer
was also clearly stained. In part of the germinal layer,
some cells were aggregated, likely forming pre-brood
capsules. Importantly, PSC were found in some brood
capsules and each capsule contained more than one PSC
including immature and mature PSC (Fig. 2b, c).
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In order to establish an in vivo animal model, we
transferred 30 of the small, 300–500 μm in diameter
sized cultured vesicles intraperitoneally into each of 10
female BALB/c mice (weight, 18–22 g) using a method
described previously [17]. The mice were sacrificed
6 months post-infection. The subsequent lesion tissue/
masses were removed from the peritoneal cavity of the
mice for weighing and histological analysis. All the mice
were successfully infected with the E. multilocularis tis-
sue lesions forming many large tumor-like structures.
The mean weight of the metacestode masses was
10.06 ± 3.58 g per mouse. Histological staining showed
that the vesicles possessed the typical structure of a
metacestode with a germinal membrane, a laminated
layer, and brood capsules with mature and immature
PSC (Fig. 3). This successful infection indicated that
the in vitro cultured vesicles could be used as seeds
for further infecting mice for maintaining the parasite
in the laboratory.
Several studies have described the establishment of an
in vitro cultivation system for E. multilocularis metaces-
todes. The first attempts were undertaken in the 1990s
by Hemphill & Gottstein [14] and Jura et al. [15] using
co-cultivation of host feeder cells and metacestode
vesicles (fibroblasts in the “tissue block” method of
Hemphill et al.; metacestodes with hepatocytes in the
presence of a collagen matrix forming “sandwich config-
uration” method of Jura et al.). Subsequently, Spiliotis
et al. (2004) [16] developed an in vitro system for a
long-term cultivation of E. multilocularis larvae which
depended strictly on reducing and anaerobic conditions.
However, the growth of metacestode vesicles and differ-
entiation towards the protoscolex stage only occurred in
culture medium that was pre-conditioned by hepatoma
cells. In 2008, Spiliotis & Brehm [18] established a large-
scale cultivation system which utilized homogenized
metacestode tissue that was incubated in liquid culture
together with rat hepatoma feeder cells. The disadvan-
tage of these culture methods was the requirement for
the continuous presence of host cells. However, in this
study, we have described a simple method which in-
volves a medium containing a large amount of FBS
(25 %) which allows PSC to redifferentiate into vesicles.
The generated vesicles were able to produce PSC in vitro
in the absence of host feeder cells, indicating that the
high concentration of FBS likely contains sufficient es-
sential growth factors for PSC growth and proliferation/
differentiation. The advantage of this procedure and its
comparison with other methods are described in Table 1.
To obtain host cell-free cultured parasites, we used two
procedures to remove possible host contamination: di-
gestion with pepsin and washing. Before culture, we
Fig. 1 Light microscopy image of E. multilocularis vesicles obtained from protoscoleces cultured in vitro on day 1 (a), day 7 (b), day 15 (c), and
day 60 (d). Abbreviations: E-PSC, evaginated PSC; H, hooks; LL, laminated layer; I-PSC, invaginated PSC; PSC, protoscoleces; SU, suckers; S-PSC, “swollen”
PSC. Scale-bars: 500 μm
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digested the parasite materials with pepsin and then
washed the preparation five times with PBS. We then
cultured the larval parasites in a feeder cell-free medium
for more than 100 days. To determine whether the cul-
ture system required a high concentration of FBS, we
used a low concentration of FBS (10 %) in the culture
medium. We found PSC/microvesicles could not be
maintained for more than six weeks, indicating that a
high concentration of FBS is a key factor for PSC growth
and differentiation. The success of culturing PSC to
vesicles which in turn produced PSC indicates that larval
E. multilocularis can be maintained in culture vessels in
vitro. In addition, we showed that RPMI1640 is better
than other media, such as MEM, for promoting PSC dif-
ferentiation and maintenance [19].
Conclusions
We have developed a simple and practical in vitro cul-
ture method for generating vesicles from PSC of E. mul-
tilocularis which in turn produced PSC in vitro in the
Fig. 3 Echinococcus multilocularis metacestode and protoscolex development in mice. Cultured small vesicles were transferred into the peritoneal
cavity of mice. a Metacestode masses of E. multilocularis in a mouse. b Hematoxylin and eosin staining of E. multilocularis lesion tissue section on
a slide. Abbreviations: BC, brood capsule; PSC, protoscoleces. Scale-bar: 10 μm
Fig. 2 Protoscoleces cultured in vitro at day 100 (a) and toluidine blue staining of the vesicles (b, magnification: 100×; c, magnification: 400×).
Vesicles obtained from in vitro culture showing a developed brood capsule containing mature and developing protoscoleces. Abbreviations: BC,
brood capsule; Pre-BC, pre-brood capsule; PSC, protoscoleces
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absence of host feeder cells. This successful development
of vesicles in a host feeder cell-free cultivation system
represents a useful model for investigating the biology of
E. multilocularis and for screening drugs for treatment
of alveolar echinococcosis. Furthermore, we have devel-
oped a method for the secondary infection of E. multilo-
cularis by simply transferring the cultured vesicles into
the peritoneal cavity of mice, which provides a valuable
animal model for investigating parasite development and
elucidating host-parasite interactions.
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